Skip to content
FDA drug shortage status

Is Ketorolac Tromethamine Injection in shortage?

Yes. Ketorolac Tromethamine Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

In shortageFDA status
22packages listed
13unavailable

Why it’s in shortage

  • Delay in shipping of the drug
  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)
    Baxter HealthcareIn shortageAvailableUpdated Nov 18, 2026

    Maker contact: 888-229-0001

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release not available at this time. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release not available at this time. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Estimated recovery: TBD

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Estimated recovery: TBD

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Estimated recovery: TBD

    Maker contact: 888-386-1300

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: December 2027

    Maker contact: 844-646-4398

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)
    Sagent PharmaceuticalsIn shortageLimited AvailabilityUpdated Nov 6, 2026

    Estimated recovery: Mid-November 2026, Product in transit and expected to arrive week of Nov 12th

    Maker contact: 866-625-1618

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)
    Sagent PharmaceuticalsIn shortageAvailableUpdated Nov 6, 2026

    Maker contact: 866-625-1618

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)
    Sagent PharmaceuticalsIn shortageUnavailableUpdated Nov 6, 2026

    Product in transit with expected delivery in December 2026

    Maker contact: 866-625-1618

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)
    Baxter HealthcareIn shortageUnavailableUpdated Nov 3, 2026

    Estimated recovery: December 2026

    Maker contact: 888-229-0001

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)
    Gland Pharma LimitedIn shortageAvailableUpdated Oct 21, 2026

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    Maker contact: 833-291-9645

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)
    Gland Pharma LimitedIn shortageAvailableUpdated Oct 21, 2026

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    Maker contact: 833-291-9645

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Oct 14, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Oct 14, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Oct 14, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)
    Alembic PharmaceuticalsIn shortageAvailableUpdated May 15, 2026

    Maker contact: 908-393-9604

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)
    Alembic PharmaceuticalsIn shortageAvailableUpdated May 15, 2026

    Maker contact: 908-393-9604

  • Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)
    Alembic PharmaceuticalsIn shortageAvailableUpdated May 15, 2026

    Maker contact: 908-393-9604

FDA recalls of Ketorolac Tromethamine

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Ketorolac Tromethamine Injection:

Other forms on FDA’s list

Ketorolac Tromethamine Injection shortage questions

Is Ketorolac Tromethamine Injection in shortage?

Yes. Ketorolac Tromethamine Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

Why is there a Ketorolac Tromethamine Injection shortage?

FDA records the reason as: Delay in shipping of the drug; Demand increase for the drug; Other.

What should I do if I can’t get Ketorolac Tromethamine Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.